Is FeNOtyping in COPD the path to precision medicine?
Respirology · 2023-05 · 28 (5) · 421-422
DOI: 10.1111/resp.14474 ↗At a glance
Editorial in Respirology, published online on 2023-02-21. Written by Cara Flynn and 1 co-authors. Institution: NIHR Biomedical Research Centre, Institute for Lung Health, University of Leicester, Leicester, UK. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Asthma. Cited 12 times so far (Crossref); 14 references. Funded by: NIHR Biomedical Research Centre Leicester.
Topics: COPD
Abstract (original language)
See related article
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- NIHR Biomedical Research Centre, Institute for Lung Health, University of Leicester, Leicester, UK.
ORCID profiles: Chris Brightling
Funding
- NIHR Biomedical Research Centre Leicester
Cite
APA
Flynn, C., & Brightling, C. (2023). Is FeNOtyping in COPD the path to precision medicine?. Respirology, 28(5), 421-422. https://doi.org/10.1111/resp.14474
Vancouver
Flynn C, Brightling C. Is FeNOtyping in COPD the path to precision medicine?. Respirology. 2023;28(5):421-422. doi:10.1111/resp.14474
BibTeX
@article{Flynn2023,
author = {Flynn, Cara and Brightling, Chris},
title = {Is FeNOtyping in COPD the path to precision medicine?},
journal = {Respirology},
year = {2023},
volume = {28},
number = {5},
pages = {421--422},
doi = {10.1111/resp.14474}
}
EUVIMED